Contributing to the advancement of genomics in Latin America, China-headquartered MGI Tech Co., a company committed to building core tools and technology to lead life science, has announced the launch of its Customer Experience Center (CEC) in Brazil.  

The goal is to provide a facility for clinical and research laboratories, hospitals, and universities to enhance learning and experience with genetic sequencing technology, applied in precision medicine, oncology, agrigenomics (application of the genome in agriculture) and metagenomics (collection of genomes of environmental microbial communities), among other segments.

The lab will also play a role as MGI Hub in Brazil, allowing the expansion of operations across Latin America. It demonstrates MGI's enduring dedication to broadening global genomics accessibility in this region. MGI has been operating in Latin Americas since 2019 and has already partnered with many clients, such as Fundação Oswaldo Cruz (Fiocruz) in Brazil, Biogenar in Argentina, Gencell in Colombia, Genos in Mexico and TCL Group in Chile.

In Brazil, MGI's technology also supports the largest Brazilian genomic sequencing project, which aims to sequence the complete genomes of thousands of patients with rare diseases and hereditary cancers, searching for genetic markers to track inherited diseases for early diagnosis.

MGI operates in 100 countries and has other 9 Customer Experience Centers around the world. The Brazilian center, located in Brooklin Paulista, in São Paulo, will provide a place for clinical laboratories, universities, and hospitals to engage in demonstrations, enhancing their education and experience with the company's technology. Highly skilled professionals will lead certified training sessions, demonstrations, evaluations and local new application support.